Evidence that Supports Re-directing the Immune System with Aptamers (Chemically Programmable Immunity, Dr Kary Mullis) would Work Against COVID-19: “Until a coronavirus vaccine is ready, pneumonia vaccines may reduce deaths from COVID-19”

https://news.yahoo.com/until-coronavirus-vaccine-ready-pneumonia-191844263.htmlThe higher the rate of pneumococcal vaccination, the lower COVID-19 morbidity and mortality. Vaccination rates with Bacillus Calmette–Guerin, poliovirus, and other vaccines do not affect these COVID-19 numbers, nor do COVID-19 case or death rates follow the numbers of people with diabetes, obesity, or who are over 65. Infant protection may be due to maternal antibodies and antiviral proteins in milk such as lactoferrin that are known to protect against coronavirus infections. Protection might be further provided by rates of Haemophilus influenzae type B (Hib) (universal in infants) and pneumococcal vaccination, the latter varying widely among nations for infants, at-risk adults, and elderly.
The huge differences in the incidence of severe COVID-19 cases and deaths from one nation to another might be due to population density, number of elderly, how and when social distancing restrictions or other protective measures are implemented. It is difficult to explain differences in COVID-19 death rates that vary from between 650 per million to 65 per million in neighboring European nations or death rates as low as 0.5 per million in some Asian nations. The rate of vaccination against Haemophilus influenzae type B and pneumococcal infections by Streptococcus pneumoniae may make the difference in preventing fatal COVID infection outcomes. https:onlinelibrary.wiley.com/doi/epdf/10.1002/bies.202000076. One last caveat, association does not prove causation. This beneficial effect could be extended or enhanced by using aptamer linkers with the current vaccine antigen at one end and the aptamer, selected in vitro for binding to the SARS-CoV-2 (spike) antigens, at the other end of the aptamer, Chemically Programmable Immunity.